Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation-Reference-Cited by-同舟云学术

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation

Published:2002-01 Issue:1 Volume:12 Page:59-61
ISSN:1053-4296
Container-title:Seminars in Radiation Oncology
language:en
Short-container-title:Seminars in Radiation Oncology

Author:

Arquette Matthew,Wasserman Todd,Govindan Ramaswamy,Garfield David,Senzer Neil,Gillenwater Heidi,Socinski Mark

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference9 articles.

1. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: An update of Cancer and Leukemia Group B study 8083;Perry;J Clin Oncol,1998

2. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: A phase II study of the Southwest Oncology Group (SWOG-9229);Thomas;Int J Radiat Oncol Biol Phys,1998

3. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide;Turrisi;N Engl J Med,1999

4. Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: Results of a phase II trial;Tannehill;J Clin Oncol,1997

5. Assessment of the protective effect of amifostine on radiation induced pulmonary toxicity;Vujaskovic;Int J Radiat Oncol Biol Phys,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity Management for Thorax Tumors in Radiation Oncology;Prevention and Management of Acute and Late Toxicities in Radiation Oncology;2020

2. Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update;Lung Cancer: Targets and Therapy;2018-09

3. Management of Normal Tissue Toxicity Associated With Chemoradiation (Primary Skin, Esophagus, and Lung);The Cancer Journal;2013-05

4. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients;Supportive Care in Cancer;2012-11-10

5. Radiation Injury;Sleisenger and Fordtran's Gastrointestinal and Liver Disease;2010